Graft failure in patients receiving T cell-depleted HLA-identical allogeneic marrow transplants.
Paul J. Martin(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), H. Joachim Deeg(Fred Hutch Cancer Center), John A. Hansen(University of Washington), Keith M. Sullivan(Duke Medical Center), John O’Quigley(University College London), Jan‐Stephan Sanders(Tufts University), Donna Przepiorka(The University of Texas MD Anderson Cancer Center), Beverly Torok‐Storb(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), RP Witherspoon, Diane M. Durnam
PubMed
September 1, 1988
Cited by 195
Related Papers
National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group Report
|Biology of Blood and Marrow Transplantation|2014|5.4k
Chronic graft-versus-host syndrome in man
|The American Journal of Medicine|1980|2.4k
Methotrexate and Cyclosporine Compared with Cyclosporine Alone for Prophylaxis of Acute Graft versus Host Disease after Marrow Transplantation for Leukemia
|New England Journal of Medicine|1986|1.5k